Saturday, November 23, 2024
HomeTagsRare Intractable Diseases

Rare Intractable Diseases

MaxCyte Signs Platform License with Curamys to Enable Cell & Gene Therapies for the Treatment

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics